Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$596.8K
5 trades · 2 insiders
Net · 90d
$-596.8K
Insiders on file
40
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Marantz Jing L. | EVP, Chief Medical Officer | 2 | $0 | $0 | 2026-10-26 |
| Dube Michael P | VP, PAO and Interim PFO | 10 | $0 | $207.4K | 2026-10-02 |
| LEONARD JOHN M. | President and CEO, Director | 154 | $0 | $55.26M | 2026-08-21 |
| Dulac Edward J III | EVP, Chief Financial Officer | 10 | $0 | $338.8K | 2026-07-22 |
| Bhanji Muna | Director | 17 | $0 | $95.8K | 2026-06-09 |
| Keresty Georgia | Director | 16 | $0 | $0 | 2026-06-09 |
| GOODMAN JESSE | Director | 17 | $0 | $29.1K | 2026-06-09 |
| CHASE WILLIAM J | Director | 11 | $1.00M | $0 | 2026-06-09 |
| Goff Brian | Director | 6 | $0 | $0 | 2026-06-09 |
| Verwiel Frank | Director | 17 | $0 | $37.6K | 2026-06-09 |
| Cohen Fred E | Director | 19 | $1.40M | $0 | 2026-06-09 |
| Clark Eliana | EVP, Chief Technical Officer | 28 | $0 | $690.4K | 2026-03-02 |
| BASTA JAMES | EVP, General Counsel | 22 | $0 | $499.7K | 2026-03-02 |
| Schultes Birgit C | EVP, Chief Scientific Officer | 6 | $0 | $78.9K | 2026-03-01 |
| Lebwohl David | EVP, Chief Medical Officer | 55 | $0 | $2.37M | 2026-03-01 |
| Hicks Derek | EVP, Chief Business Officer | 9 | $0 | $260.8K | 2025-01-03 |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 49 | $0 | $19.26M | 2025-01-03 |
| Goddard Glenn | See Remarks | 45 | $0 | $8.79M | 2024-03-01 |
| Crowley John F | Director | 17 | $0 | $1.60M | 2023-06-14 |
| DORSA CAROLINE | Director | 16 | $0 | $616.4K | 2022-06-14 |
| FORMELA JEAN FRANCOIS | Director | 63 | $0 | $155.43M | 2022-06-14 |
| Rivera Jose E | EVP, General Counsel & Ops | 97 | $0 | $9.82M | 2021-04-01 |
| SCHIERMEIER ANDREW | EVP, Dev and Corp Strategy | 16 | $117.9K | $76.9K | 2021-03-03 |
| KARSEN PERRY A | Director | 17 | $0 | $4.75M | 2020-12-17 |
| Bell Graeme | EVP, Chief Financial Officer | 7 | $0 | $0 | 2018-03-28 |
| Caribou Biosciences, Inc. | 10% Owner | 2 | $0 | $14.75M | 2018-01-29 |
| Novartis Institutes for BioMedical Research, Inc. | 10% Owner | 9 | $5.00M | $27.87M | 2017-12-12 |
| Bermingham Nessan | President & CEO | 10 | $0 | $7.00M | 2017-12-12 |
| Slaoui Moncef | Director | 1 | $0 | $0 | 2017-07-25 |
| Atlas Venture Associates IX, L.P. | 10% Owner | 6 | $0 | $2.73M | 2017-07-11 |
| GORDON CARL L | Director, 10% Owner | 8 | $4.50M | $0 | 2017-05-18 |
| Heifner Nicole | SVP, Accounting | 1 | $0 | $0 | 2017-01-06 |
| Morrissey David V | SVP, Platform & Delivery Tech | 1 | $0 | $0 | 2017-01-06 |
| Barnes Thomas M. | SVP, R&D eXtellia | 1 | $0 | $0 | 2017-01-06 |
| Caribou Therapeutics Holdco, LLC | 10% Owner | 4 | $0 | $0 | 2016-05-11 |
| Atlas Venture Associates IX, LLC | 10% Owner | 8 | $0 | $0 | 2016-05-11 |
| Haurwitz Rachel E. | Director, 10% Owner | 5 | $0 | $0 | 2016-05-11 |
| BAKER JULIAN | Other | 6 | $3.60M | $0 | 2016-05-11 |
| ISALY SAMUEL D | Director | 6 | $4.50M | $0 | 2016-05-11 |
| Temasek Holdings (Private) Ltd | 10% Owner | 3 | $5.40M | $0 | 2016-05-11 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Marantz Jing L. | EVP, Chief Medical Officer | A Award deriv | 2026-10-26 | 2026-10-28 | 275,061 | — | $0 | 275,061 | SEC↗ |
| Marantz Jing L. | EVP, Chief Medical Officer | A Award | 2026-10-26 | 2026-10-28 | 199,822 | — | $0 | 199,822 | SEC↗ |
| Dube Michael P | VP, Chief Accounting Officer | S Sale | 2026-10-02 | 2026-10-06 | 1,864 | $12.43 | $23.2K | 65,022 | SEC↗ |
| LEONARD JOHN M | President and CEO | S Sale | 2026-08-21 | 2026-08-24 | 2,785 | $13.00 | $36.2K | 1,147,064 | SEC↗ |
| LEONARD JOHN M | President and CEO, Director | S Sale | 2026-08-21 | 2026-08-24 | 2,785 | $13.00 | $36.2K | 1,147,064 | SEC↗ |
| LEONARD JOHN M | President and CEO | S Sale | 2026-08-20 | 2026-08-24 | 19,890 | $12.60 | $250.6K | 1,149,849 | SEC↗ |
| LEONARD JOHN M | President and CEO, Director | S Sale | 2026-08-20 | 2026-08-24 | 19,890 | $12.60 | $250.6K | 1,149,849 | SEC↗ |
| Dulac Edward J III | EVP, Chief Financial Officer | S Sale | 2026-07-22 | 2026-07-24 | 8,111 | $11.25 | $91.2K | 148,175 | SEC↗ |
| Dulac Edward J III | EVP, Chief Financial Officer | S Sale | 2026-07-02 | 2026-07-06 | 4,677 | $18.00 | $84.2K | 156,286 | SEC↗ |
| Dube Michael P | VP, Chief Accounting Officer | S Sale | 2026-07-01 | 2026-07-06 | 2,641 | $16.78 | $44.3K | 66,886 | SEC↗ |
| Bhanji Muna | Director | A Award deriv | 2026-06-09 | 2026-06-10 | 13,300 | — | $0 | 13,300 | SEC↗ |
| CHASE WILLIAM J | Director | A Award deriv | 2026-06-09 | 2026-06-10 | 13,300 | — | $0 | 13,300 | SEC↗ |
| Cohen Fred E | Director | A Award deriv | 2026-06-09 | 2026-06-10 | 13,300 | — | $0 | 13,300 | SEC↗ |
| Goff Brian | Director | A Award deriv | 2026-06-09 | 2026-06-10 | 13,300 | — | $0 | 13,300 | SEC↗ |
| GOODMAN JESSE | Director | A Award deriv | 2026-06-09 | 2026-06-10 | 13,300 | — | $0 | 13,300 | SEC↗ |
| Keresty Georgia | Director | A Award deriv | 2026-06-09 | 2026-06-10 | 13,300 | — | $0 | 13,300 | SEC↗ |
| Verwiel Frank | Director | A Award deriv | 2026-06-09 | 2026-06-10 | 13,300 | — | $0 | 13,300 | SEC↗ |
| Bhanji Muna | Director | A Award | 2026-06-09 | 2026-06-10 | 9,200 | — | $0 | 36,403 | SEC↗ |
| CHASE WILLIAM J | Director | A Award | 2026-06-09 | 2026-06-10 | 9,200 | — | $0 | 143,893 | SEC↗ |
| Cohen Fred E | Director | A Award | 2026-06-09 | 2026-06-10 | 9,200 | — | $0 | 216,653 | SEC↗ |
| Goff Brian | Director | A Award | 2026-06-09 | 2026-06-10 | 9,200 | — | $0 | 32,609 | SEC↗ |
| GOODMAN JESSE | Director | A Award | 2026-06-09 | 2026-06-10 | 9,200 | — | $0 | 33,559 | SEC↗ |
| Keresty Georgia | Director | A Award | 2026-06-09 | 2026-06-10 | 9,200 | — | $0 | 41,083 | SEC↗ |
| Verwiel Frank | Director | A Award | 2026-06-09 | 2026-06-10 | 9,200 | — | $0 | 35,148 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2026-03-02 | 2026-03-03 | 607 | $13.78 | $8.4K | 93,864 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | S Sale | 2026-03-02 | 2026-03-03 | 1,211 | $13.78 | $16.7K | 156,794 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 10,505 | — | $0 | 10,505 | SEC↗ |
| Schultes Birgit C | EVP, Chief Scientific Office | A Award deriv | 2026-03-01 | 2026-03-03 | 56,000 | — | $0 | 56,000 | SEC↗ |
| Dulac Edward J III | EVP, Chief Financial Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 87,543 | — | $0 | 87,543 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 14,204 | — | $0 | 14,204 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | A Award deriv | 2026-03-01 | 2026-03-03 | 65,829 | — | $0 | 65,829 | SEC↗ |
| LEONARD JOHN M | President and CEO | A Award deriv | 2026-03-01 | 2026-03-03 | 225,400 | — | $0 | 225,400 | SEC↗ |
| Dube Michael P | VP, Chief Accounting Officer | A Award | 2026-03-01 | 2026-03-03 | 17,250 | — | $0 | 69,527 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | A Award | 2026-03-01 | 2026-03-03 | 7,353 | — | $0 | 94,471 | SEC↗ |
| Schultes Birgit C | EVP, Chief Scientific Office | A Award | 2026-03-01 | 2026-03-03 | 39,200 | — | $0 | 137,733 | SEC↗ |
| Dulac Edward J III | EVP, Chief Financial Officer | A Award | 2026-03-01 | 2026-03-03 | 61,280 | — | $0 | 160,963 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | A Award | 2026-03-01 | 2026-03-03 | 9,943 | — | $0 | 131,192 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | A Award | 2026-03-01 | 2026-03-03 | 46,080 | — | $0 | 158,005 | SEC↗ |
| LEONARD JOHN M | President and CEO | A Award | 2026-03-01 | 2026-03-03 | 156,400 | — | $0 | 1,169,739 | SEC↗ |
| Dube Michael P | VP, Chief Accounting Officer | S Sale | 2026-01-05 | 2026-01-07 | 2,989 | $9.21 | $27.5K | 52,277 | SEC↗ |
| Dulac Edward J III | EVP, Chief Financial Officer | S Sale | 2026-01-05 | 2026-01-07 | 6,379 | $9.21 | $58.8K | 99,683 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2026-01-05 | 2026-01-07 | 9,515 | $9.21 | $87.6K | 87,118 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2026-01-05 | 2026-01-07 | 11,903 | $9.21 | $109.6K | 121,249 | SEC↗ |
| Cohen Fred E | Director | P Buy | 2026-01-05 | 2026-01-07 | 150,000 | $9.35 | $1.40M | 207,453 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | S Sale | 2026-01-05 | 2026-01-07 | 10,397 | $9.21 | $95.8K | 101,528 | SEC↗ |
| Schultes Birgit C | EVP, Chief Scientific Office | S Sale | 2026-01-05 | 2026-01-07 | 8,508 | $9.21 | $78.4K | 98,533 | SEC↗ |
| LEONARD JOHN M | President and CEO | S Sale | 2026-01-05 | 2026-01-07 | 34,146 | $9.21 | $314.5K | 1,013,339 | SEC↗ |
| LEONARD JOHN M | President and CEO | M Exercise deriv | 2025-12-12 | 2025-12-12 | 8,557 | — | $0 | 0 | SEC↗ |
| LEONARD JOHN M | President and CEO | M Exercise | 2025-12-12 | 2025-12-12 | 8,557 | $6.83 | $58.4K | 1,047,485 | SEC↗ |
| LEONARD JOHN M | President and CEO | M Exercise deriv | 2025-12-11 | 2025-12-12 | 49,959 | — | $0 | 8,557 | SEC↗ |
| LEONARD JOHN M | President and CEO | S Sale | 2025-12-11 | 2025-12-12 | 49,959 | $9.49 | $474.1K | 1,077,115 | SEC↗ |
| LEONARD JOHN M | President and CEO | S Sale | 2025-12-11 | 2025-12-12 | 32,832 | $9.47 | $310.9K | 1,044,283 | SEC↗ |
| LEONARD JOHN M | President and CEO | S Sale | 2025-12-11 | 2025-12-12 | 5,355 | $9.59 | $51.4K | 1,038,928 | SEC↗ |
| LEONARD JOHN M | President and CEO | M Exercise | 2025-12-11 | 2025-12-12 | 49,959 | $6.83 | $341.2K | 1,127,074 | SEC↗ |
| Dube Michael P | VP, Chief Accounting Officer | S Sale | 2025-10-01 | 2025-10-03 | 1,871 | $17.38 | $32.5K | 55,266 | SEC↗ |
| Schultes Birgit C | EVP, Chief Scientific Office | S Sale | 2025-10-01 | 2025-10-03 | 31 | $17.38 | $539 | 105,184 | SEC↗ |
| CHASE WILLIAM J | Director | P Buy | 2025-08-20 | 2025-08-22 | 100,000 | $10.03 | $1.00M | 134,693 | SEC↗ |
| Dulac Edward J III | EVP, Chief Financial Officer | S Sale | 2025-07-23 | 2025-07-25 | 7,462 | $14.02 | $104.6K | 106,062 | SEC↗ |
| Dube Michael P | VP, Chief Accounting Officer | S Sale | 2025-07-02 | 2025-07-03 | 2,503 | $9.95 | $24.9K | 57,137 | SEC↗ |
| GOODMAN JESSE | Director | S Sale | 2025-07-01 | 2025-07-02 | 1,547 | $9.23 | $14.3K | 24,359 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2025-07-01 | 2025-07-03 | 1,022 | $9.82 | $10.0K | 95,369 | SEC↗ |
| GOODMAN JESSE | Director | S Sale | 2025-06-30 | 2025-07-02 | 1,547 | $9.56 | $14.8K | 25,906 | SEC↗ |
| Cohen Fred E | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 11,450 | — | $0 | 11,450 | SEC↗ |
| CHASE WILLIAM J | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 11,450 | — | $0 | 11,450 | SEC↗ |
| Bhanji Muna | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 11,450 | — | $0 | 11,450 | SEC↗ |
| Goff Brian | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 11,450 | — | $0 | 11,450 | SEC↗ |
| GOODMAN JESSE | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 11,450 | — | $0 | 11,450 | SEC↗ |
| Verwiel Frank | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 11,450 | — | $0 | 11,450 | SEC↗ |
| Keresty Georgia | Director | A Award deriv | 2025-06-11 | 2025-06-18 | 11,450 | — | $0 | 11,450 | SEC↗ |
| Cohen Fred E | Director | A Award | 2025-06-11 | 2025-06-13 | 8,000 | — | $0 | 57,453 | SEC↗ |
| CHASE WILLIAM J | Director | A Award | 2025-06-11 | 2025-06-13 | 8,000 | — | $0 | 34,693 | SEC↗ |
| Bhanji Muna | Director | A Award | 2025-06-11 | 2025-06-13 | 8,000 | — | $0 | 27,203 | SEC↗ |
| Goff Brian | Director | A Award | 2025-06-11 | 2025-06-13 | 8,000 | — | $0 | 23,409 | SEC↗ |
| GOODMAN JESSE | Director | A Award | 2025-06-11 | 2025-06-13 | 8,000 | — | $0 | 27,453 | SEC↗ |
| Verwiel Frank | Director | A Award | 2025-06-11 | 2025-06-13 | 8,000 | — | $0 | 25,948 | SEC↗ |
| Keresty Georgia | Director | A Award | 2025-06-11 | 2025-06-18 | 8,000 | — | $0 | 31,883 | SEC↗ |
| Bhanji Muna | Director | S Sale | 2025-04-29 | 2025-05-01 | 265 | $8.50 | $2.3K | 19,203 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | S Sale | 2025-03-04 | 2025-03-04 | 2,572 | $8.99 | $23.1K | 111,925 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2025-03-04 | 2025-03-04 | 679 | $8.99 | $6.1K | 95,369 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | A Award deriv | 2025-03-01 | 2025-03-04 | 57,143 | — | $0 | 57,143 | SEC↗ |
| Schultes Birgit C | EVP, Chief Scientific Office | A Award deriv | 2025-03-01 | 2025-03-04 | 53,714 | — | $0 | 53,714 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | A Award deriv | 2025-03-01 | 2025-03-04 | 61,714 | — | $0 | 61,714 | SEC↗ |
| Dulac Edward J III | EVP, Chief Financial Officer | A Award deriv | 2025-03-01 | 2025-03-04 | 67,429 | — | $0 | 67,429 | SEC↗ |
| LEONARD JOHN M | President and CEO | A Award deriv | 2025-03-01 | 2025-03-04 | 196,000 | — | $0 | 196,000 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | A Award deriv | 2025-03-01 | 2025-03-04 | 45,714 | — | $0 | 45,714 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | A Award | 2025-03-01 | 2025-03-04 | 40,000 | — | $0 | 114,497 | SEC↗ |
| Schultes Birgit C | EVP, Chief Scientific Office | A Award | 2025-03-01 | 2025-03-04 | 37,600 | — | $0 | 105,215 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | A Award | 2025-03-01 | 2025-03-04 | 43,200 | — | $0 | 130,866 | SEC↗ |
| Dube Michael P | VP, Chief Accounting Officer | A Award | 2025-03-01 | 2025-03-04 | 14,000 | — | $0 | 59,640 | SEC↗ |
| Dulac Edward J III | EVP, Chief Financial Officer | A Award | 2025-03-01 | 2025-03-04 | 47,200 | — | $0 | 113,524 | SEC↗ |
| LEONARD JOHN M | President and CEO | A Award | 2025-03-01 | 2025-03-04 | 136,000 | — | $0 | 1,077,115 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | A Award | 2025-03-01 | 2025-03-04 | 32,000 | — | $0 | 96,048 | SEC↗ |
| Bhanji Muna | Director | S Sale | 2025-01-29 | 2025-01-31 | 265 | $9.97 | $2.6K | 19,468 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2025-01-03 | 2025-01-06 | 7,422 | $12.18 | $90.4K | 64,048 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | S Sale | 2025-01-03 | 2025-01-07 | 8,966 | $12.18 | $109.2K | 77,388 | SEC↗ |
| LEONARD JOHN M | President and CEO | S Sale | 2025-01-03 | 2025-01-07 | 26,807 | $12.18 | $326.5K | 941,115 | SEC↗ |
| Hicks Derek | EVP, Chief Business Officer | S Sale | 2025-01-03 | 2025-01-07 | 6,502 | $12.18 | $79.2K | 59,878 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2025-01-03 | 2025-01-07 | 9,557 | $12.18 | $116.4K | 87,666 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | S Sale | 2025-01-03 | 2025-01-07 | 7,074 | $12.18 | $86.2K | 74,497 | SEC↗ |
| Dube Michael P | VP, Chief Accounting Officer | S Sale | 2025-01-03 | 2025-01-07 | 1,372 | $12.18 | $16.7K | 45,640 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2025-01-02 | 2025-01-06 | 556 | $12.03 | $6.7K | 71,470 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | M Exercise deriv | 2025-01-01 | 2025-01-03 | 3,500 | — | $0 | 0 | SEC↗ |
| LEONARD JOHN M | President and CEO | M Exercise deriv | 2025-01-01 | 2025-01-03 | 7,850 | — | $0 | 0 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise deriv | 2025-01-01 | 2025-01-03 | 3,189 | — | $0 | 0 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | M Exercise | 2025-01-01 | 2025-01-03 | 3,500 | — | $0 | 86,354 | SEC↗ |
| LEONARD JOHN M | President and CEO | M Exercise | 2025-01-01 | 2025-01-03 | 7,850 | — | $0 | 967,922 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise | 2025-01-01 | 2025-01-03 | 3,189 | — | $0 | 97,223 | SEC↗ |
| Dube Michael P | VP, Chief Accounting Officer | S Sale | 2024-10-02 | 2024-10-04 | 2,012 | $19.01 | $38.2K | 47,012 | SEC↗ |
| Dulac Edward J III | EVP, Chief Financial Officer | A Award deriv | 2024-07-22 | 2024-07-24 | 96,219 | — | $0 | 96,219 | SEC↗ |
| Dulac Edward J III | EVP, Chief Financial Officer | A Award | 2024-07-22 | 2024-07-24 | 66,324 | — | $0 | 66,324 | SEC↗ |
| Dube Michael P | VP, PAO and Interim PFO | A Award | 2024-07-01 | 2024-07-03 | 17,801 | — | $0 | 49,024 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2024-07-01 | 2024-07-03 | 405 | $22.93 | $9.3K | 71,470 | SEC↗ |
| Verwiel Frank | Director | S Sale | 2024-06-17 | 2024-06-20 | 1,505 | $25.00 | $37.6K | 17,948 | SEC↗ |
| Goff Brian | Director | A Award deriv | 2024-06-13 | 2024-06-17 | 22,297 | — | $0 | 22,297 | SEC↗ |
| Goff Brian | Director | A Award | 2024-06-13 | 2024-06-17 | 15,409 | — | $0 | 15,409 | SEC↗ |
| CHASE WILLIAM J | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 11,515 | — | $0 | 11,515 | SEC↗ |
| Bhanji Muna | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 11,515 | — | $0 | 11,515 | SEC↗ |
| Cohen Fred E | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 11,515 | — | $0 | 11,515 | SEC↗ |
| GOODMAN JESSE | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 11,515 | — | $0 | 11,515 | SEC↗ |
| Keresty Georgia | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 11,515 | — | $0 | 11,515 | SEC↗ |
| Verwiel Frank | Director | A Award deriv | 2024-06-12 | 2024-06-14 | 11,515 | — | $0 | 11,515 | SEC↗ |
| CHASE WILLIAM J | Director | A Award | 2024-06-12 | 2024-06-14 | 7,737 | — | $0 | 26,693 | SEC↗ |
| Bhanji Muna | Director | A Award | 2024-06-12 | 2024-06-14 | 7,737 | — | $0 | 19,733 | SEC↗ |
| Cohen Fred E | Director | A Award | 2024-06-12 | 2024-06-14 | 7,737 | — | $0 | 49,453 | SEC↗ |
| GOODMAN JESSE | Director | A Award | 2024-06-12 | 2024-06-14 | 7,737 | — | $0 | 19,453 | SEC↗ |
| Keresty Georgia | Director | A Award | 2024-06-12 | 2024-06-14 | 7,737 | — | $0 | 23,883 | SEC↗ |
| Verwiel Frank | Director | A Award | 2024-06-12 | 2024-06-14 | 7,737 | — | $0 | 19,453 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2024-03-04 | 2024-03-05 | 605 | $32.99 | $20.0K | 71,470 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | S Sale | 2024-03-04 | 2024-03-05 | 2,297 | $32.99 | $75.8K | 81,571 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | A Award deriv | 2024-03-01 | 2024-03-05 | 41,316 | — | $0 | 41,316 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | A Award deriv | 2024-03-01 | 2024-03-05 | 45,072 | — | $0 | 45,072 | SEC↗ |
| Hicks Derek | EVP, Chief Business Officer | A Award deriv | 2024-03-01 | 2024-03-05 | 42,421 | — | $0 | 42,421 | SEC↗ |
| LEONARD JOHN M | President and CEO | A Award deriv | 2024-03-01 | 2024-03-05 | 163,929 | — | $0 | 163,929 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | A Award deriv | 2024-03-01 | 2024-03-05 | 55,855 | — | $0 | 55,855 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | A Award deriv | 2024-03-01 | 2024-03-05 | 46,752 | — | $0 | 46,752 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | A Award deriv | 2024-03-01 | 2024-03-05 | 54,794 | — | $0 | 54,794 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | A Award | 2024-03-01 | 2024-03-05 | 28,628 | — | $0 | 69,213 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | A Award | 2024-03-01 | 2024-03-05 | 31,230 | — | $0 | 72,075 | SEC↗ |
| Hicks Derek | EVP, Chief Business Officer | A Award | 2024-03-01 | 2024-03-05 | 29,393 | — | $0 | 66,380 | SEC↗ |
| LEONARD JOHN M | President and CEO | A Award | 2024-03-01 | 2024-03-05 | 113,586 | — | $0 | 960,072 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | A Award | 2024-03-01 | 2024-03-05 | 38,701 | — | $0 | 93,073 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | A Award | 2024-03-01 | 2024-03-05 | 32,394 | — | $0 | 83,868 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | A Award | 2024-03-01 | 2024-03-05 | 37,966 | — | $0 | 81,893 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | S Sale | 2024-01-08 | 2024-01-10 | 1,608 | $28.66 | $46.1K | 44,594 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | S Sale | 2024-01-08 | 2024-01-10 | 667 | $29.38 | $19.6K | 43,927 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2024-01-03 | 2024-01-05 | 4,301 | $29.46 | $126.7K | 40,845 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2024-01-03 | 2024-01-05 | 307 | $30.12 | $9.2K | 45,146 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | S Sale | 2024-01-03 | 2024-01-05 | 3,805 | $29.46 | $112.1K | 51,474 | SEC↗ |
| Hicks Derek | EVP, Chief Business Officer | S Sale | 2024-01-03 | 2024-01-05 | 3,877 | $29.46 | $114.2K | 36,987 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | S Sale | 2024-01-03 | 2024-01-05 | 5,365 | $29.46 | $158.1K | 40,585 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | S Sale | 2024-01-03 | 2024-01-05 | 5,532 | $29.46 | $163.0K | 46,202 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2024-01-03 | 2024-01-05 | 5,843 | $29.46 | $172.1K | 54,372 | SEC↗ |
| LEONARD JOHN M | President and CEO | S Sale | 2024-01-03 | 2024-01-05 | 19,223 | $29.46 | $566.3K | 846,486 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | M Exercise deriv | 2024-01-01 | 2024-01-03 | 3,062 | — | $0 | 3,064 | SEC↗ |
| LEONARD JOHN M | President and CEO | M Exercise deriv | 2024-01-01 | 2024-01-03 | 7,848 | — | $0 | 7,850 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise deriv | 2024-01-01 | 2024-01-03 | 3,187 | — | $0 | 3,189 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | M Exercise deriv | 2024-01-01 | 2024-01-03 | 3,500 | — | $0 | 3,500 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | M Exercise | 2024-01-01 | 2024-01-03 | 3,062 | — | $0 | 45,950 | SEC↗ |
| LEONARD JOHN M | President and CEO | M Exercise | 2024-01-01 | 2024-01-03 | 7,848 | — | $0 | 865,709 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise | 2024-01-01 | 2024-01-03 | 3,187 | — | $0 | 60,215 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | M Exercise | 2024-01-01 | 2024-01-03 | 3,500 | — | $0 | 51,734 | SEC↗ |
| Bhanji Muna | Director | S Sale | 2023-10-31 | 2023-11-02 | 265 | $23.90 | $6.3K | 11,996 | SEC↗ |
| Bhanji Muna | Director | S Sale | 2023-07-31 | 2023-08-02 | 265 | $42.33 | $11.2K | 12,261 | SEC↗ |
| Bhanji Muna | Director | S Sale | 2023-07-06 | 2023-07-10 | 1,867 | $39.30 | $73.4K | 12,526 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2023-07-03 | 2023-07-06 | 360 | $40.51 | $14.6K | 45,146 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | M Exercise deriv | 2023-06-20 | 2023-06-22 | 5,000 | — | $0 | 57,750 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2023-06-20 | 2023-06-22 | 5,000 | $45.00 | $225.0K | 45,146 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | M Exercise | 2023-06-20 | 2023-06-22 | 5,000 | $12.27 | $61.4K | 50,146 | SEC↗ |
| Bhanji Muna | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 6,473 | — | $0 | 6,473 | SEC↗ |
| Cohen Fred E | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 6,473 | — | $0 | 6,473 | SEC↗ |
| Crowley John F | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 6,473 | — | $0 | 6,473 | SEC↗ |
| GOODMAN JESSE | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 6,473 | — | $0 | 6,473 | SEC↗ |
| Keresty Georgia | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 6,473 | — | $0 | 6,473 | SEC↗ |
| Verwiel Frank | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 6,473 | — | $0 | 6,473 | SEC↗ |
| CHASE WILLIAM J | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 2,447 | — | $0 | 2,447 | SEC↗ |
| Bhanji Muna | Director | A Award | 2023-06-14 | 2023-06-16 | 4,425 | — | $0 | 14,393 | SEC↗ |
| Cohen Fred E | Director | A Award | 2023-06-14 | 2023-06-16 | 4,425 | — | $0 | 41,716 | SEC↗ |
| Crowley John F | Director | A Award | 2023-06-14 | 2023-06-16 | 4,425 | — | $0 | 11,716 | SEC↗ |
| GOODMAN JESSE | Director | A Award | 2023-06-14 | 2023-06-16 | 4,425 | — | $0 | 11,716 | SEC↗ |
| Keresty Georgia | Director | A Award | 2023-06-14 | 2023-06-16 | 4,425 | — | $0 | 16,146 | SEC↗ |
| Verwiel Frank | Director | A Award | 2023-06-14 | 2023-06-16 | 4,425 | — | $0 | 11,716 | SEC↗ |
| CHASE WILLIAM J | Director | A Award | 2023-06-14 | 2023-06-16 | 1,673 | — | $0 | 18,956 | SEC↗ |
| CHASE WILLIAM J | Director | A Award deriv | 2023-04-14 | 2023-04-18 | 14,931 | — | $0 | 14,931 | SEC↗ |
| CHASE WILLIAM J | Director | A Award | 2023-04-14 | 2023-04-18 | 10,483 | — | $0 | 17,283 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | S Sale | 2023-03-02 | 2023-03-03 | 1,088 | $43.88 | $47.7K | 55,279 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | A Award deriv | 2023-03-01 | 2023-03-03 | 34,674 | — | $0 | 34,674 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 34,674 | — | $0 | 34,674 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | A Award deriv | 2023-03-01 | 2023-03-03 | 42,302 | — | $0 | 42,302 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 43,342 | — | $0 | 43,342 | SEC↗ |
| LEONARD JOHN M | President and CEO | A Award deriv | 2023-03-01 | 2023-03-03 | 128,631 | — | $0 | 128,631 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 38,834 | — | $0 | 38,834 | SEC↗ |
| Hicks Derek | EVP, Chief Business Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 33,287 | — | $0 | 33,287 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | A Award | 2023-03-01 | 2023-03-03 | 24,539 | — | $0 | 44,098 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | A Award | 2023-03-01 | 2023-03-03 | 12,269 | — | $0 | 56,367 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | A Award | 2023-03-01 | 2023-03-03 | 24,539 | — | $0 | 39,012 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | A Award | 2023-03-01 | 2023-03-03 | 6,134 | — | $0 | 45,146 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | A Award | 2023-03-01 | 2023-03-03 | 29,938 | — | $0 | 47,567 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | A Award | 2023-03-01 | 2023-03-03 | 30,674 | — | $0 | 56,361 | SEC↗ |
| LEONARD JOHN M | President and CEO | A Award | 2023-03-01 | 2023-03-03 | 91,036 | — | $0 | 857,861 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | A Award | 2023-03-01 | 2023-03-03 | 27,484 | — | $0 | 42,888 | SEC↗ |
| Hicks Derek | EVP, Chief Business Officer | A Award | 2023-03-01 | 2023-03-03 | 23,558 | — | $0 | 40,864 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | S Sale | 2023-01-05 | 2023-01-06 | 689 | $39.10 | $26.9K | 17,629 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | S Sale | 2023-01-05 | 2023-01-06 | 1,641 | $38.22 | $62.7K | 18,318 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | S Sale | 2023-01-04 | 2023-01-06 | 1,138 | $37.21 | $42.3K | 19,559 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2023-01-04 | 2023-01-06 | 1,692 | $37.21 | $63.0K | 14,473 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | S Sale | 2023-01-04 | 2023-01-06 | 2,427 | $37.21 | $90.3K | 15,404 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2023-01-04 | 2023-01-06 | 2,574 | $37.21 | $95.8K | 25,687 | SEC↗ |
| Hicks Derek | EVP, Chief Business Officer | S Sale | 2023-01-04 | 2023-01-06 | 1,812 | $37.21 | $67.4K | 17,306 | SEC↗ |
| LEONARD JOHN M | President and CEO | S Sale | 2023-01-04 | 2023-01-06 | 6,673 | $37.21 | $248.3K | 766,825 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | S Sale | 2023-01-04 | 2023-01-06 | 2,508 | $37.21 | $93.3K | 19,959 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2023-01-03 | 2023-01-06 | 231 | $34.48 | $8.0K | 16,165 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | M Exercise deriv | 2023-01-01 | 2023-01-04 | 3,062 | — | $0 | 6,126 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise deriv | 2023-01-01 | 2023-01-04 | 3,187 | — | $0 | 6,376 | SEC↗ |
| LEONARD JOHN M | President and CEO | M Exercise deriv | 2023-01-01 | 2023-01-04 | 7,848 | — | $0 | 15,698 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | M Exercise deriv | 2023-01-01 | 2023-01-04 | 3,500 | — | $0 | 7,000 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | M Exercise | 2023-01-01 | 2023-01-04 | 3,062 | — | $0 | 17,831 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise | 2023-01-01 | 2023-01-04 | 3,187 | — | $0 | 28,261 | SEC↗ |
| LEONARD JOHN M | President and CEO | M Exercise | 2023-01-01 | 2023-01-04 | 7,848 | — | $0 | 773,498 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | M Exercise | 2023-01-01 | 2023-01-04 | 3,500 | — | $0 | 22,467 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | S Sale | 2022-07-01 | 2023-01-06 | 105 | $51.74 | $5.4K | 16,165 | SEC↗ |
| Bhanji Muna | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 2,980 | — | $0 | 2,980 | SEC↗ |
| Cohen Fred E | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 7,688 | — | $0 | 7,688 | SEC↗ |
| Crowley John F | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 7,688 | — | $0 | 7,688 | SEC↗ |
| DORSA CAROLINE | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 7,688 | — | $0 | 7,688 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 7,688 | — | $0 | 7,688 | SEC↗ |
| GOODMAN JESSE | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 7,688 | — | $0 | 7,688 | SEC↗ |
| Keresty Georgia | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 7,688 | — | $0 | 7,688 | SEC↗ |
| Verwiel Frank | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 7,688 | — | $0 | 7,688 | SEC↗ |
| Bhanji Muna | Director | A Award | 2022-06-14 | 2022-06-16 | 2,014 | — | $0 | 9,968 | SEC↗ |
| Cohen Fred E | Director | A Award | 2022-06-14 | 2022-06-16 | 5,197 | — | $0 | 37,291 | SEC↗ |
| Crowley John F | Director | A Award | 2022-06-14 | 2022-06-16 | 5,197 | — | $0 | 7,291 | SEC↗ |
| DORSA CAROLINE | Director | A Award | 2022-06-14 | 2022-06-16 | 5,197 | — | $0 | 12,701 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director | A Award | 2022-06-14 | 2022-06-16 | 5,197 | — | $0 | 7,291 | SEC↗ |
| GOODMAN JESSE | Director | A Award | 2022-06-14 | 2022-06-16 | 5,197 | — | $0 | 7,291 | SEC↗ |
| Keresty Georgia | Director | A Award | 2022-06-14 | 2022-06-16 | 5,197 | — | $0 | 11,721 | SEC↗ |
| Verwiel Frank | Director | A Award | 2022-06-14 | 2022-06-16 | 5,197 | — | $0 | 7,291 | SEC↗ |
| Bhanji Muna | Director | A Award deriv | 2022-04-28 | 2022-05-02 | 11,700 | — | $0 | 11,700 | SEC↗ |
| Bhanji Muna | Director | A Award | 2022-04-28 | 2022-05-02 | 7,954 | — | $0 | 7,954 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | A Award deriv | 2022-03-01 | 2022-03-03 | 9,648 | — | $0 | 9,648 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | A Award deriv | 2022-03-01 | 2022-03-03 | 12,720 | — | $0 | 12,720 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | A Award deriv | 2022-03-01 | 2022-03-03 | 13,816 | — | $0 | 13,816 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | A Award deriv | 2022-03-01 | 2022-03-03 | 13,816 | — | $0 | 13,816 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | A Award deriv | 2022-03-01 | 2022-03-04 | 20,203 | — | $0 | 20,203 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | A Award deriv | 2022-03-01 | 2022-03-04 | 20,203 | — | $0 | 20,203 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | A Award deriv | 2022-03-01 | 2022-03-04 | 18,600 | — | $0 | 18,600 | SEC↗ |
| LEONARD JOHN M | President and CEO | A Award deriv | 2022-03-01 | 2022-03-04 | 59,941 | — | $0 | 59,941 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | A Award deriv | 2022-03-01 | 2022-03-04 | 14,109 | — | $0 | 14,109 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | A Award deriv | 2022-03-01 | 2022-03-07 | 15,395 | — | $0 | 15,395 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | A Award | 2022-03-01 | 2022-03-03 | 9,648 | — | $0 | 20,697 | SEC↗ |
| BASTA JAMES | EVP, General Counsel | A Award | 2022-03-01 | 2022-03-03 | 11,049 | — | $0 | 11,049 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | A Award | 2022-03-01 | 2022-03-03 | 12,720 | — | $0 | 14,769 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | A Award | 2022-03-01 | 2022-03-03 | 13,816 | — | $0 | 24,738 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | A Award | 2022-03-01 | 2022-03-03 | 13,816 | — | $0 | 18,631 | SEC↗ |
| LEONARD JOHN M | President and CEO | A Award | 2022-03-01 | 2022-03-04 | 40,990 | — | $0 | 765,650 | SEC↗ |
| Clark Eliana | EVP, Chief Technical Officer | A Award | 2022-03-01 | 2022-03-07 | 10,527 | — | $0 | 16,165 | SEC↗ |
| Hicks Derek | EVP, Chief Business Officer | A Award deriv | 2022-01-03 | 2022-01-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hicks Derek | EVP, Chief Business Officer | A Award | 2022-01-03 | 2022-01-05 | 19,118 | — | $0 | 19,118 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | M Exercise deriv | 2022-01-01 | 2022-03-03 | 3,062 | — | $0 | 9,188 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise deriv | 2022-01-01 | 2022-03-03 | 3,187 | — | $0 | 9,563 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | M Exercise deriv | 2022-01-01 | 2022-03-03 | 3,500 | — | $0 | 10,500 | SEC↗ |
| LEONARD JOHN M | President and CEO | M Exercise deriv | 2022-01-01 | 2022-03-04 | 7,848 | — | $0 | 23,546 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | M Exercise | 2022-01-01 | 2022-03-03 | 3,062 | — | $0 | 3,062 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | S Sale | 2022-01-01 | 2022-03-03 | 1,013 | $112.24 | $113.7K | 2,049 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise | 2022-01-01 | 2022-03-03 | 3,187 | — | $0 | 11,973 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2022-01-01 | 2022-03-03 | 1,051 | $112.24 | $118.0K | 10,922 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | M Exercise | 2022-01-01 | 2022-03-03 | 3,500 | — | $0 | 5,963 | SEC↗ |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Office | S Sale | 2022-01-01 | 2022-03-03 | 1,148 | $112.25 | $128.9K | 4,815 | SEC↗ |
| LEONARD JOHN M | President and CEO | S Sale | 2022-01-01 | 2022-03-04 | 2,493 | $112.26 | $279.9K | 724,660 | SEC↗ |
| LEONARD JOHN M | President and CEO | M Exercise | 2022-01-01 | 2022-03-04 | 7,848 | — | $0 | 727,153 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise deriv | 2021-11-05 | 2021-11-09 | 2,400 | — | $0 | 180,077 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2021-11-05 | 2021-11-09 | 1,200 | $131.71 | $158.1K | 9,914 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise | 2021-11-05 | 2021-11-09 | 2,400 | $12.62 | $30.3K | 11,114 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2021-11-05 | 2021-11-09 | 548 | $134.07 | $73.5K | 8,914 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2021-11-05 | 2021-11-09 | 200 | $135.34 | $27.1K | 8,714 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2021-11-05 | 2021-11-09 | 452 | $132.62 | $59.9K | 9,462 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise deriv | 2021-10-14 | 2021-10-15 | 2,400 | — | $0 | 182,477 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise | 2021-10-14 | 2021-10-15 | 2,400 | $12.62 | $30.3K | 11,114 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2021-10-14 | 2021-10-15 | 849 | $127.81 | $108.5K | 9,714 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2021-10-14 | 2021-10-15 | 225 | $129.01 | $29.0K | 9,489 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2021-10-14 | 2021-10-15 | 525 | $129.83 | $68.2K | 8,964 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2021-10-14 | 2021-10-15 | 250 | $130.47 | $32.6K | 8,714 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2021-10-14 | 2021-10-15 | 551 | $126.92 | $69.9K | 10,563 | SEC↗ |
| Crowley John F | Director | M Exercise deriv | 2021-10-11 | 2021-10-13 | 2,500 | — | $0 | 25,500 | SEC↗ |
| Crowley John F | Director | M Exercise | 2021-10-11 | 2021-10-13 | 2,500 | $18.83 | $47.1K | 4,594 | SEC↗ |
| Crowley John F | Director | S Sale | 2021-10-11 | 2021-10-13 | 2,500 | $119.55 | $298.9K | 2,094 | SEC↗ |
| Crowley John F | Director | M Exercise deriv | 2021-10-05 | 2021-10-07 | 10,000 | — | $0 | 28,000 | SEC↗ |
| Crowley John F | Director | S Sale | 2021-10-05 | 2021-10-07 | 1,280 | $128.83 | $164.9K | 10,814 | SEC↗ |
| Crowley John F | Director | M Exercise | 2021-10-05 | 2021-10-07 | 10,000 | $18.83 | $188.3K | 12,094 | SEC↗ |
| Crowley John F | Director | S Sale | 2021-10-05 | 2021-10-07 | 3,759 | $130.92 | $492.1K | 4,140 | SEC↗ |
| Crowley John F | Director | S Sale | 2021-10-05 | 2021-10-07 | 1,846 | $131.74 | $243.2K | 2,294 | SEC↗ |
| Crowley John F | Director | S Sale | 2021-10-05 | 2021-10-07 | 200 | $132.84 | $26.6K | 2,094 | SEC↗ |
| Crowley John F | Director | S Sale | 2021-10-05 | 2021-10-07 | 2,915 | $129.88 | $378.6K | 7,899 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise deriv | 2021-09-24 | 2021-09-27 | 7,923 | — | $0 | 184,877 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise | 2021-09-24 | 2021-09-27 | 7,923 | $12.62 | $100.0K | 8,714 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise deriv | 2021-09-21 | 2021-09-23 | 2,400 | — | $0 | 192,800 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | M Exercise | 2021-09-21 | 2021-09-23 | 2,400 | $12.62 | $30.3K | 3,191 | SEC↗ |
| Lebwohl David | EVP, Chief Medical Officer | S Sale | 2021-09-21 | 2021-09-23 | 2,400 | $149.81 | $359.5K | 791 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | M Exercise deriv | 2021-09-07 | 2021-09-09 | 3,482 | — | $0 | 12,451 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | S Sale | 2021-09-07 | 2021-09-09 | 3,482 | $180.12 | $627.2K | 0 | SEC↗ |
| Goddard Glenn | EVP, Chief Financial Officer | M Exercise | 2021-09-07 | 2021-09-09 | 3,482 | $14.58 | $50.8K | 3,482 | SEC↗ |